Publication | Closed Access

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use

PsychopharmacologySocial SciencesCerebrospinal FluidAddiction MedicinePsychoactive Substance UseNeurologyCannabinoidsCannabis UsePsychoactive DrugPsychiatryNeuropharmacologyCannabisSubstance AbuseAddictionSchizophreniaNeuroscienceBiological PsychiatryAnandamide LevelsMedicine